logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Genocea Biosciences, Inc.


USPTO Granted Patents = 17

% Expired Patents = 35.3



Trademarks = 2

Forward Citations = 52

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Jessica Baker Flechtner (12 out of 13 patents)

silverMedal Todd Michael Gierahn (9 out of 23 patents)

bronzeMedal Richard Malley (5 out of 28 patents)

4.  Deborah Long (5 out of 5 patents)

5.  Mojca Skoberne (5 out of 5 patents)

6.  George Rainer Siber (3 out of 26 patents)

7.  Marie Lossky-Elias (1 out of 1 patent)

8.  Pamela M Carroll (1 out of 1 patent)

9.  Hubert Lam (1 out of 1 patent)

10.  Lisa K McNeil (1 out of 1 patent)

11.  Wendy Jane Broom (1 out of 1 patent)

12.  Seth Vollmer Hetherington (1 out of 1 patent)

13.  Jessica Flechtner (0 patent)

14.  Jessica Flechtner (0 patent)

15.  Jessica Fletchner (0 patent)


17 patents:

1. 11207375 - Vaccines and compositions against (2021-12-28),
2. 11162093 - Antigen screening system (2021-11-02),
3. 10859566 - Treatment methods (2020-12-08),
4. 10653771 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2020-05-19),
5. 10570387 - Antigen screening system (2020-02-25),
6. 10350288 - Methods and compositions for treating herpes (2019-07-16),
7. 10188717 - [object Object] (2019-01-29),
8. 10105412 - [object Object] (2018-10-23),
9. 9895436 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2018-02-20),
10. 9873870 - Antigen screening system (2018-01-23),
11. 9782474 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2017-10-10),
12. 9765125 - [object Object] (2017-09-19),
13. 9624273 - Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2017-04-18),
14. 9393294 - [object Object] (2016-07-19),
15. 9045791 - Antigen screening system (2015-06-02),
Company Overview
Genocea Biosciences, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative immunotherapies for infectious diseases and cancer. The company focuses on harnessing the power of T cell responses to create targeted therapies that aim to enhance the immune system's ability to fight diseases. Genocea's proprietary platform enables the identification of novel antigens, paving the way for the advancement of personalized medicine and improved treatment options in the field of immunology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#158 in Cambridge, MA

#1,150 in Massachusetts

#18,894 in US

#35,918 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Genocea Biosciences, Inc.

Forward Citations = 52

12 inventors:

goldMedal Jessica Baker Flechtner (12 out of 13 patents)

silverMedal Todd Michael Gierahn (9 out of 23 patents)

bronzeMedal Richard Malley (5 out of 28 patents)

4.  Deborah Long (5 out of 5 patents)

5.  Mojca Skoberne (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genocea Biosciences, Inc.. Retrieved from https://idiyas.com/company/genocea-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…